Hexagon Nutrition quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Year before	Change
Revenue	104	—	—
EBITDA	11.7	—	—
EBITDA margin	11.3%	—	—
Profit before tax	10.6	—	—
Net profit	8.1	—	—
EPS	₹0.67	—	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026

Expenses
	104	115
	2.1	4.0
	106	119
	67.1	55.3
	1.3	0.0
	−9.8	9.3
	13.6	14.4
	1.0	1.1
	2.3	2.7
	20.5	21.0
	95.8	104
	11.7	15.1
	9.4	12.3
Profit
	10.5	15.1
	0.1	0.3
	10.6	15.4
	3.8	4.4
	−1.3	0.1
	2.5	4.5
	8.1	10.9
	8.1	10.9
	0.4	0.8
	8.4	11.7
	8.1	10.9
Per share
	₹0.67	₹0.99
	₹0.66	₹0.89
Other comprehensive income — detail
	0.4	0.8
	0.1	0.8
	0.0	0.0
	0.3	—
	0.4	11.7
Per share — as-filed variants
	₹0.67	₹0.99
	₹0.66	₹0.89
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	45.8	50.5
	43.9%	43.9%
Adjusted (ex-exceptional items) — derived
	10.5	15.1
	0.1	0.3
	8.0	10.7
	₹0.67	₹0.97

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HEXAGON₹57.32

Hexagon Nutrition Limited

· Pharma & Health

Annual Quarterly₹ CroreMcap ₹634 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	115.0	104.3
Other Income	4.0	2.1
Total Income	119.0	106.4
Expenses
+ Cost of Materials Consumed	55.3	67.1
+ Purchases of Stock-in-Trade	0.0	1.3
+ Changes in Inventories	9.3	-9.8
+ Employee Benefit Expense	14.4	13.6
+ Finance Costs	1.1	1.0
+ Depreciation & Amortisation	2.7	2.3
+ Other Expenses	21.0	20.5
Total Expenses	103.9	95.8
EBITDA	15.1	11.7
EBIT	12.3	9.4
Profit
PBT before Exceptional Items	15.1	10.5
+ Exceptional Items	0.3	0.1
Pretax Income	15.4	10.6
+ Current Tax	4.4	3.8
+ Deferred Tax	0.1	-1.3
Tax Expense	4.5	2.5
Net Income	10.9	8.1
+ Net Income — Continuing Ops	10.9	8.1
+ Other Comprehensive Income	0.8	0.4
Total Comprehensive Income	11.7	8.4
Net Income to Common	10.9	8.1
Per Share
Basic EPS	0.99	0.67
Diluted EPS	0.89	0.66
Other Comprehensive Income — detail
+ Other Comprehensive Income	0.8	0.4
+ Items NOT to be Reclassified to P&L	0.8	0.1
+ Tax on Items NOT to be Reclassified	0.0	0.0
+ Items to be Reclassified to P&L	—	0.3
Comprehensive Income — Owners of Parent	11.7	0.4
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.99	0.67
Diluted EPS — Continuing Operations	0.89	0.66
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	50.5	45.8
Gross Margin %	43.87	43.91
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	15.1	10.5
− Exceptional Items (reconciliation)	0.3	0.1
Net Income Adj (tax-effected)	10.7	8.0
EPS Adj	0.97	0.67
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00
Paid Up Equity Capital	11.1	12.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Hexagon Nutrition quarterly results

Hexagon Nutrition (NSE: HEXAGON) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹8.1 crore, down 26.0% from ₹10.9 crore in Q4 FY26. Revenue from operations was ₹104 crore, down 9.3% from the previous quarter.

Q1 FY27 results (the latest): 12 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹8.1 Cr−26.0% vs Q4 FY26
Q1 FY27 revenue: ₹104 Cr−9.3% vs Q4 FY26
Q1 FY27 operating margin: 9.1%−1.6 pts vs Q4 FY26
Q1 FY27 EPS (basic): ₹0.67

Questions

When will Hexagon Nutrition announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33).

What were Hexagon Nutrition's Q1 FY27 results?

Consolidated net profit was ₹8.1 crore, down 26.0% from ₹10.9 crore in Q4 FY26. Revenue from operations was ₹104 crore, down 9.3% from the previous quarter.

What was Hexagon Nutrition's net profit in FY26?

Consolidated net profit was ₹37.9 crore in FY26 (April 2025–March 2026).

What was Hexagon Nutrition's revenue in FY26?

Revenue from operations was ₹383 crore in FY26 (April 2025–March 2026).

Where do these Hexagon Nutrition figures come from?

From Hexagon Nutrition's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.